MYRIAD GENETICS INC. - COMMON STOCK

Myriad Genetics Included in Forbes America’s Best Employers 2025 List

19 Feb 2025 08:30:00 By Nasdaq GlobeNewswire

Myriad Genetics to Release Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025

18 Feb 2025 08:30:00 By Nasdaq GlobeNewswire

Myriad Genetics and CancerCARE for Life Announce Agreement to Advance Access to MyRisk with RiskScore Hereditary Cancer Test

06 Feb 2025 08:30:00 By Nasdaq GlobeNewswire

Myriad Genetics Announces Two New Patents Granted for its Molecular Residual Disease (MRD) Assay

05 Feb 2025 16:15:00 By Nasdaq GlobeNewswire

Myriad Genetics and Lumea Collaborate to Enhance Access to the Prolaris Biomarker and MyRisk Hereditary Cancer Tests through BxLink Integration

05 Feb 2025 08:30:00 By Nasdaq GlobeNewswire

Myriad Genetics Unveils Groundbreaking Eight Weeks’ Gestation NIPT Study Results at Society for Maternal-Fetal Medicine Conference

29 Jan 2025 08:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

23 Jan 2025 10:36:25 By NetDania Notify

Myriad Genetics Introduces Online Prenatal Genetic Testing Resource

23 Jan 2025 08:30:00 By Nasdaq GlobeNewswire

Myriad Genetics Announces Hereditary Cancer Risk Assessment Program Study Published in Obstetrics & Gynecology

21 Jan 2025 08:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

16 Jan 2025 09:49:01 By NetDania Notify

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

15 Jan 2025 10:51:04 By NetDania Notify

Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2024 Financial Results and Introduces Full Year 2025 Financial Guidance

15 Jan 2025 08:30:00 By Nasdaq GlobeNewswire

Myriad Genetics Signs Agreement with Nationally Renowned Sports Broadcaster Hannah Storm to Promote the Importance of Knowing Family Cancer History

09 Jan 2025 16:30:00 By Nasdaq GlobeNewswire

UPDATE – Myriad Genetics to Present at 43rd Annual J.P. Morgan Healthcare Conference

08 Jan 2025 11:27:21 By Nasdaq GlobeNewswire

Myriad Genetics to Present at 43rd Annual J.P. Morgan Healthcare Conference

08 Jan 2025 08:00:01 By Nasdaq GlobeNewswire

MD Anderson and Myriad Genetics form strategic alliance to evaluate clinical utility of Myriad’s molecular residual disease assay

07 Jan 2025 08:00:00 By Nasdaq GlobeNewswire

Myriad Genetics Issues Quality, Innovation, and Corporate Responsibility Report

06 Jan 2025 08:00:00 By Nasdaq GlobeNewswire

Myriad Genetics’ RiskScore Study Named One of the Top 10 Significant Advances in Genomic Medicine in American Journal of Human Genetics

19 Dec 2024 16:15:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

19 Dec 2024 09:46:28 By NetDania Notify

NetDania - New 12 months Low: MYRIAD GENETICS INC. - COMMON STOCK

18 Dec 2024 09:58:51 By NetDania Notify